These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer. Bui KT; Willson ML; Goel S; Beith J; Goodwin A Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074 [TBL] [Abstract][Full Text] [Related]
4. Risk-reducing medications for primary breast cancer: a network meta-analysis. Mocellin S; Goodwin A; Pasquali S Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012191. PubMed ID: 31032883 [TBL] [Abstract][Full Text] [Related]
5. Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Roberts KE; Rickett K; Feng S; Vagenas D; Woodward NE Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012988. PubMed ID: 31994181 [TBL] [Abstract][Full Text] [Related]
6. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Roberts KE; Adsett IT; Rickett K; Conroy SM; Chatfield MD; Woodward NE Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013167. PubMed ID: 35005781 [TBL] [Abstract][Full Text] [Related]
7. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Romero SA; Young K; Hickey M; Su HI Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007245. PubMed ID: 33348436 [TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401 [TBL] [Abstract][Full Text] [Related]
9. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women. Goel S; Sharma R; Hamilton A; Beith J Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD004562. PubMed ID: 19821328 [TBL] [Abstract][Full Text] [Related]
10. Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies. Aldin A; Umlauff L; Estcourt LJ; Collins G; Moons KG; Engert A; Kobe C; von Tresckow B; Haque M; Foroutan F; Kreuzberger N; Trivella M; Skoetz N Cochrane Database Syst Rev; 2019 Sep; 9(9):CD012643. PubMed ID: 31525824 [TBL] [Abstract][Full Text] [Related]
12. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Dominick S; Hickey M; Chin J; Su HI Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916 [TBL] [Abstract][Full Text] [Related]
18. Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery. Chung C; Bryant A; Brown PD Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011492. PubMed ID: 29987845 [TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women. Gibson LJ; Dawson C; Lawrence DH; Bliss JM Cochrane Database Syst Rev; 2007 Jan; (1):CD003370. PubMed ID: 17253488 [TBL] [Abstract][Full Text] [Related]
20. Interventions for promoting habitual exercise in people living with and beyond cancer. Turner RR; Steed L; Quirk H; Greasley RU; Saxton JM; Taylor SJ; Rosario DJ; Thaha MA; Bourke L Cochrane Database Syst Rev; 2018 Sep; 9(9):CD010192. PubMed ID: 30229557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]